Aspirin Chewable Tablets recalled over foreign material
- Recall date
- February 23, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Mckesson Packaging Services recalls Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist. B…
- Recall number
- D-0513-2017
- FDA classification
- Class II
- Brand / firm
- Mckesson Packaging Services
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Presence of Foreign Substance: foreign material found in the bulk inventory.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist. By: McKesson Packaging Services, a business unit of McKesson Corporation, 7101 Weddington Rd., Concord, NC 28027, NDC 63739-434-01.
Get recall alerts
Free email alert whenever Mckesson Packaging Services has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mckesson Packaging Services